z-logo
open-access-imgOpen Access
Phenotypic and Molecular Epidemiology of ESBL-, AmpC-, and Carbapenemase-Producing Escherichia coli in Northern and Eastern Europe
Author(s) -
Epp Sepp,
Reidar Andreson,
Arta Balode,
Anastasia Bilozor,
Age Brauer,
S. A. Egorova,
Kristi Huik,
Marina Ivanova,
Л. А. Кафтырева,
Siiri Kõljalg,
Triinu Kõressaar,
М. А. Макарова,
Jolanta Miciulevičienė,
Kristiine Pai,
Maido Remm,
Tiiu Rööp,
Paul Naaber
Publication year - 2019
Publication title -
frontiers in microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.701
H-Index - 135
ISSN - 1664-302X
DOI - 10.3389/fmicb.2019.02465
Subject(s) - biology , escherichia coli , genotype , multilocus sequence typing , cephalosporin , molecular epidemiology , microbiology and biotechnology , phenotype , gene , genetics , antibiotics
Extended-spectrum beta-lactamases (ESBL) and AmpC producing- Escherichia coli have spread worldwide, but data about ESBL-producing- E. coli in the Northern and Eastern regions of Europe is scant. The aim of this study has been to describe the phenotypical and molecular epidemiology of different ESBL/AmpC/Carbapenemases genes in E. coli strains isolated from the Baltic States (Estonia, Latvia, and Lithuania), Norway and St. Petersburg (Russia), and to determine the predominant multilocus sequence type and single nucleotide polymorphisms diversity of E. coli isolates deduced by whole genome sequencing (WGS). A total of 10,780 clinical E. coli strains were screened for reduced sensitivity to third-generation cephalosporins. They were collected from 21 hospitals located in Estonia, Latvia, Lithuania, Norway and St. Petersburg during a 5 month period in 2012. The overall prevalence of ESBL/AmpC strains was 4.7% by phenotypical test and 3.9% by sequencing. We found more strains with the ESBL/AmpC phenotype and genotype in St. Petersburg and Latvia than other countries. Of phenotypic E. coli strains, 85% contained confirmed ESBL genes (including bla CTX–M , bla TEM– 29 , bla TEM– 71 ), AmpC genes ( bla CMY– 59 , bla ACT– 12 / – 15 / – 20 , bla ESC– 6 , bla FEC– 1 , bla DHA– 1 ), or carbapenemase genes ( bla NDM– 1 ). bla CTX–M– 1 , bla CTX–M – 14 and bla CTX–M– 15 were found in all countries, but bla CTX–M– 15 prevalence was higher in Latvia than in St. Petersburg (Russia), Estonia, Norway and Lithuania. The dominating AmpC genes were bla CMY– 59 in the Baltic States and Norway, and bla DHA– 1 in St. Petersburg. E. coli strains belonged to 83 different sequence types, of which the most prevalent was ST131 (40%). In conclusion, we generally found low ESBL/AmpC/Carbapenemase prevalence in E. coli strains isolated in Northern/Eastern Europe. However, several inter-country differences in distribution of particular genes and multilocus sequence types were found.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom